Home | BioBucks

Latest Editions of BioBucks

Aug 26, 2026

Wednesday: ARCH's $1.5B China NewCo and Jazz's 26.4-month OS

Plus: Zymeworks banks $250M and falls 7%. Bristol Myers walks.

Aug 25, 2026

Tuesday: Merck's 3rd IRA loss and a 23% gene therapy gut-punch

Aug 24, 2026

Monday: Roche pays $190M up front to keep the muscle on

Aug 21, 2026

Friday: BMS rents AI models, Amgen walks from $500M in milestones

Aug 20, 2026

Thursday: Moderna's 177% day and two first-ever approvals

Aug 19, 2026

Wednesday: Trump's FDA pick and BioMarin's $275M bone bet

Aug 18, 2026

Tuesday: EyePoint's 70% wipeout hits wet AMD

Aug 17, 2026

Monday: AstraZeneca's 895-patient bispecific bet folds

Aug 14, 2026

Friday: BMS lands the first CELMoD at $29,500 a cycle

Aug 13, 2026

Thursday: Definium's LSD pill goes 2-for-2 in Phase 3